Cargando…
Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
Background. Post-kala-azar dermal leishmaniasis (PKDL) plays an important role in maintaining endemicity of visceral leishmaniasis and its transmission. Treatment regimens for PKDL are toxic and require 3-4 months of hospitalization. These long and arduous regimens result in extensive noncompliance....
Autores principales: | Sundar, Shyam, Singh, Anup, Tiwari, Anurag, Shukla, Saurabh, Chakravarty, Jaya, Rai, Madhukar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890917/ https://www.ncbi.nlm.nih.gov/pubmed/27398387 http://dx.doi.org/10.1155/2014/548010 |
Ejemplares similares
-
Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis
por: Sundar, Shyam, et al.
Publicado: (2015) -
An Unusual Presentation of Post kala-azar Dermal Leishmaniasis
por: Pathania, Sucheta, et al.
Publicado: (2020) -
Post kala-azar dermal leishmaniasis: A threat to elimination program
por: Gedda, Mallikarjuna Rao, et al.
Publicado: (2020) -
Safety and Effectiveness of Miltefosine in Post–Kala-Azar Dermal Leishmaniasis: An Observational Study
por: Sundar, Shyam, et al.
Publicado: (2023) -
Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
por: Wiwanitkit, Viroj
Publicado: (2012)